Niederle, IM; Woerns, MA; Koch, S et al.
SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) IN RELATION TO THE MELD SCORE AT INITIAL DIAGNOSIS IN A WESTERN COHORT WITH 680 PATIENTSHEPATOLOGY. Bd. 54. 2011 S. 1386A-1386A
Otto, G; Schuchmann, M; Hoppe-Lotichius, M et al.
TACE BEFORE LIVER TRANSPLANTATION: RESPONSE TO BRIDGING PREDICTS HCC RECURRENCETRANSPLANT INTERNATIONAL. Bd. 24. 2011 S. 141-141
Pitton, MB; Skowasch, M; Schneider, J et al.
TACE beim HCC im Stadium BCLC-B und –c: DC Bead-TACE versus konventionelle TACEFortschr Röntgenstr. Bd. 183. H. S1. 2011 S. S181
Weiler, N; Thrun, I; Eberlin, M et al.
TACROLIMUS SIDE EFFECTS AFTER LIVER TRANSPLANTATION: IS THERE A DIFFERENCE BETWEEN ONCE DAILY AND TWICE DAILY FORMULATION?TRANSPLANT INTERNATIONAL. Bd. 24. 2011 S. 255-255
Foltys, DB; Kaths, JM; Zimmermann, T et al.
Ten Years of Simultaneous Pancreas-Kidney Transplantation: A Retrospective Single-Center Analysis of Prospectively Obtained DataTRANSPLANTATION PROCEEDINGS. Bd. 43. H. 9. 2011 S. 3267-3269
Zimmermann, T; Hoppe-Lotichius, M; Korner, A et al.
The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantationTRANSPLANT INTERNATIONAL. Bd. 24. H. 11. 2011 S. 1059-1067
Schnitzbauer, AA; Zuelke, C; Graeb, C et al.
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinomaBMC CANCER. Bd. 10. 2010 S. -
Barreiros, AP; Geber, C; Birklein, F et al.
Clinical Symptomatic De Novo Systemic Transthyretin Amyloidosis 9 Years After Domino Liver TransplantationLIVER TRANSPLANTATION. Bd. 16. H. 1. 2010 S. 109-109
Ahmed, D; Niederle, I; Koch, S et al.
COMPARISON OF 8 STAGING SYSTEMS FOR HEPATOCELLULAR CARCINOMA (HCC) IN A WESTERN COHORT WITH 588 PATIENTSHEPATOLOGY. Bd. 52. H. 4. 2010 S. 1170A-1170A
Schmitz, T; Blaickner, M; Schutz, C et al.
Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of MainzACTA ONCOLOGICA. Bd. 49. H. 7. 2010 S. 1165-1169